280
Participants
Start Date
February 28, 2011
Primary Completion Date
November 30, 2011
Study Completion Date
April 30, 2012
Dextralgen
Dexalgen® will be administered at a dose equivalent to dexamethasone 1.5 mg, dipyrone 500 mg, and hydroxocobalamin 5 mg (one ampoule for each type) a day at a single intramuscular dose. Both drugs will be administered for 3 days, at least.
Meloxicam
Meloxicam (Movatec®, Boehringer Ingelheim) will be administered as 15 mg (one ampoule) a day at a single intramuscular dose. Both drugs will be administered for 3 days, at least.
CEDOES, Vitória
Sociedade Beneficente São Camilo, Campinas
Instituto De Pesquisa Clínica De Campinas IPECC, Campinas
Instituto de Pesquisa Clínica e Medicina Avançada Ltda IMA, São Paulo
Hospital Santa Marcelina, São Paulo
Faculdade de Medicina ABC, São Paulo
Lead Sponsor
Eurofarma Laboratorios S.A.
INDUSTRY